Index RUT P/E - EPS (ttm) -1.74 Insider Own 65.69% Shs Outstand 158.83M Perf Week 4.70%
Market Cap 2.19B Forward P/E - EPS next Y -1.56 Insider Trans -0.17% Shs Float 54.90M Perf Month 24.61%
Income -274.18M PEG - EPS next Q -0.39 Inst Own 27.63% Short Float 17.35% Perf Quarter 33.61%
Sales 0.00M P/S - EPS this Y 59.35% Inst Trans - Short Ratio 13.56 Perf Half Y -0.26%
Book/sh 2.38 P/B 5.75 EPS next Y -5.80% ROA -71.73% Short Interest 9.52M Perf Year 15.47%
Cash/sh 2.32 P/C 5.90 EPS next 5Y - ROE -77.08% 52W Range 8.33 - 21.00 Perf YTD -19.68%
Dividend Est. - P/FCF - EPS past 5Y - ROI -71.91% 52W High -34.79% Beta 3.54
Dividend TTM - Quick Ratio 17.22 Sales past 5Y 0.00% Gross Margin - 52W Low 64.40% ATR (14) 0.74
Dividend Ex-Date - Current Ratio 17.22 EPS Y/Y TTM -100.60% Oper. Margin 0.00% RSI (14) 65.47 Volatility 6.52% 6.19%
Employees 124 Debt/Eq 0.01 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 24.00
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q -45.53% Payout - Rel Volume 0.40 Prev Close 13.97
Sales Surprise - EPS Surprise 0.54% Sales Q/Q - Earnings Aug 06 BMO Avg Volume 702.58K Price 13.69
SMA20 11.62% SMA50 14.31% SMA200 6.51% Trades
Volume 119,833 Change -1.97%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-01-24 Initiated H.C. Wainwright
Buy
$30
Jul-22-24 Initiated Needham
Buy
$23
Jul-08-24 Initiated Mizuho
Outperform
$20
Dec-12-23 Initiated Deutsche Bank
Hold
$13
Oct-10-23 Initiated William Blair
Outperform
$26
Oct-10-23 Initiated Stifel
Buy
$26
Oct-10-23 Initiated RBC Capital Mkts
Outperform
$24
Oct-10-23 Initiated JP Morgan
Overweight
$21
Oct-10-23 Initiated Guggenheim
Buy
$22
Oct-10-23 Initiated BofA Securities
Buy
$18
Aug-14-24 07:00AM
Aug-06-24 01:54PM
07:00AM
Jul-01-24 01:00AM
Jun-20-24 07:00AM
08:52AM
Loading…
May-14-24 08:52AM
07:00AM
May-07-24 01:54PM
10:20AM
07:00AM
May-06-24 07:00AM
Apr-16-24 11:28AM
Apr-15-24 04:20PM
(Investor's Business Daily) -17.48%
12:17PM
08:45AM
07:47AM
Loading…
07:47AM
06:36AM
06:30AM
Mar-13-24 07:00AM
Mar-07-24 02:52PM
07:00AM
Jan-22-24 07:00AM
Jan-10-24 08:32AM
Jan-02-24 07:00AM
Dec-17-23 12:35PM
Dec-12-23 07:00AM
Nov-27-23 07:00AM
Nov-01-23 07:00AM
Oct-30-23 07:00AM
Oct-10-23 07:00AM
07:54PM
Loading…
Sep-28-23 07:54PM
(InvestorPlace) +11.84%
+6.73%
Sep-27-23 06:50PM
Sep-18-23 12:35PM
Sep-14-23 08:49PM
Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. The firm focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lenz Robert A. Head of R&D Sep 17 '24 Sale 11.81 30,788 363,736 339,205 Sep 19 04:35 PM Lenz Robert A. Head of R&D Sep 18 '24 Sale 12.09 10,676 129,091 328,529 Sep 19 04:35 PM Lenz Robert A. Officer Sep 18 '24 Proposed Sale 12.09 10,676 129,091 Sep 18 04:27 PM Lenz Robert A. Officer Sep 17 '24 Proposed Sale 11.81 30,788 363,734 Sep 17 04:37 PM Lenz Robert A. Head of R&D Sep 12 '24 Sale 11.43 32,948 376,665 369,993 Sep 16 04:05 PM Lenz Robert A. Officer Sep 12 '24 Proposed Sale 11.43 32,948 376,665 Sep 12 05:18 PM Pinto Joshua Chief Financial Officer Aug 27 '24 Sale 11.39 15,693 178,806 138,965 Aug 27 05:58 PM Pinto Joshua Chief Financial Officer Aug 26 '24 Sale 11.78 31,642 372,588 154,658 Aug 26 06:17 PM Pinto Joshua Chief Financial Officer Aug 22 '24 Sale 11.63 28,496 331,468 210,469 Aug 26 06:17 PM Pinto Joshua Chief Financial Officer Aug 23 '24 Sale 11.59 24,169 280,005 186,300 Aug 26 06:17 PM Pinto Joshua Officer Aug 22 '24 Proposed Sale 11.90 100,000 1,190,000 Aug 22 09:48 AM Burow Kristina Director Nov 13 '23 Buy 11.75 31,653 371,923 4,127,850 Nov 15 06:55 PM Burow Kristina Director Nov 14 '23 Buy 11.98 3,357 40,217 4,131,207 Nov 15 06:55 PM ARCH Venture Partners XII, LLC 10% Owner Nov 13 '23 Buy 11.75 31,653 371,923 4,127,850 Nov 15 06:54 PM ARCH Venture Partners XII, LLC 10% Owner Nov 14 '23 Buy 11.98 3,357 40,217 4,131,207 Nov 15 06:54 PM Burow Kristina Director Nov 08 '23 Buy 11.03 92,251 1,017,821 4,047,843 Nov 13 07:01 PM Burow Kristina Director Nov 09 '23 Buy 10.53 31,079 327,262 4,078,922 Nov 13 07:01 PM Burow Kristina Director Nov 10 '23 Buy 11.49 17,275 198,481 4,096,197 Nov 13 07:01 PM ARCH Venture Partners XII, LLC 10% Owner Nov 08 '23 Buy 11.03 92,251 1,017,821 4,047,843 Nov 13 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 09 '23 Buy 10.53 31,079 327,262 4,078,922 Nov 13 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 10 '23 Buy 11.49 17,275 198,481 4,096,197 Nov 13 07:00 PM Burow Kristina Director Nov 06 '23 Buy 11.55 43,082 497,597 3,925,400 Nov 07 07:00 PM Burow Kristina Director Nov 07 '23 Buy 11.50 30,192 347,208 3,955,592 Nov 07 07:00 PM Burow Kristina Director Nov 03 '23 Buy 11.38 22,420 255,140 3,882,318 Nov 07 07:00 PM ARCH Venture Partners XII, LLC 10% Owner Nov 06 '23 Buy 11.55 43,082 497,597 3,925,400 Nov 07 06:59 PM ARCH Venture Partners XII, LLC 10% Owner Nov 07 '23 Buy 11.50 30,192 347,208 3,955,592 Nov 07 06:59 PM ARCH Venture Partners XII, LLC 10% Owner Nov 03 '23 Buy 11.38 22,420 255,140 3,882,318 Nov 07 06:59 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
